Necessity of rethinking oral pediatric formulations

Daniel Bar-Shalom1

  • 1Department of Pharmacy, School of Pharmaceutical Sciences, University of Copenhagen, Copenhagen, Denmark; and Bioneer A/S, Hørsholm, Denmark.

Clinical Therapeutics
|February 18, 2014
PubMed

Insights

Formulating oral medications for children presents challenges due to developmental differences. An automated compounding system is proposed to create flexible, patient-acceptable drug formulations for pediatric use.

Area of Science:

  • Pediatric Pharmacology
  • Pharmaceutical Technology
  • Drug Delivery Systems

Background:

  • Children represent a fragmented population with diverse developmental stages and ingestion abilities.
  • Existing oral dosage formulations often fail to meet the needs of all pediatric age groups.
  • Challenges in pediatric drug formulation include palatability, dosing accuracy, and administration ease.

Purpose of the Study:

  • To review the difficulties in formulating oral pediatric medications.
  • To propose a flexible and universally acceptable formulation strategy for children.
  • To introduce an automated compounding concept for personalized pediatric drug delivery.

Main Methods:

  • Review of existing literature on pediatric oral formulation challenges.
  • Examination of developmental and ingestion variations within the pediatric population.
  • Conceptualization of an automated compounding system utilizing a flexible carrier and microencapsulated drugs.

Main Results:

  • Identification of significant formulation hurdles related to pediatric developmental diversity.
  • Proposal of a novel automated compounding approach for customized pediatric oral medications.
  • Review of key components including a pudding-like carrier, microencapsulated drug, and robotic dispensing system.

Conclusions:

  • A flexible, adaptable formulation approach is crucial for pediatric oral drug products.
  • Automated compounding at the pharmacy level offers a viable solution for personalized pediatric dosing.
  • Successful implementation requires collaboration among regulatory, clinical, and marketing stakeholders.

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
967
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
408
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
1.0K
Oral Drug Delivery Systems: Introduction01:23

Oral Drug Delivery Systems: Introduction

Oral drug delivery is the most common route of administration due to its convenience, cost-effectiveness, and high patient compliance. It enables precise formulation to ensure proper drug dosage and bioavailability. The development of oral dosage forms considers drug properties such as solubility, stability, and absorption to optimize therapeutic efficacy.Tablets, capsules, liquids, and chewable formulations enhance drug stability, mask undesirable tastes, and improve patient experience.
279
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
554
Pharmaceutical Alternatives: Polymorphic Form-Related and Particle Size-Related Therapeutic Nonequivalence01:27

Pharmaceutical Alternatives: Polymorphic Form-Related and Particle Size-Related Therapeutic Nonequivalence

Changes in polymorphic forms can significantly influence the bioavailability of poorly soluble drugs. Although the FDA defines pharmaceutical equivalence based on having the same active ingredient, dosage form, and route of administration, it does not automatically disqualify products with different polymorphic forms. This means two products with different polymorphs can still be deemed pharmaceutically equivalent. However, polymorphic differences can affect properties like wettability,...
226